Becker muscular dystrophy (BMD) is a genetic disorder characterized by progressive muscle weakness and wasting. It is caused by mutations in the dystrophin gene, which leads to a deficiency or abnormality of the dystrophin protein. BMD is similar to Duchenne muscular dystrophy (DMD), but it has a milder course and slower progression.
The diagnosis of Becker muscular dystrophy typically begins with a thorough medical history and physical examination. The healthcare provider will inquire about the patient's symptoms, family history, and any previous medical conditions. They will also assess the patient's muscle strength, range of motion, and look for any signs of muscle wasting or contractures.
Genetic testing is the most definitive method to diagnose Becker muscular dystrophy. It involves analyzing the dystrophin gene for mutations or abnormalities. This can be done through various techniques, such as DNA sequencing, multiplex ligation-dependent probe amplification (MLPA), or next-generation sequencing (NGS).
Genetic testing can identify specific mutations in the dystrophin gene that are associated with BMD. These mutations can vary in size and location, and different mutations may result in different disease severity and progression. Identifying the specific mutation can also help with genetic counseling and predicting the likelihood of passing the condition to future generations.
Electromyography (EMG) is a diagnostic procedure that measures the electrical activity of muscles. It can be useful in the diagnosis of Becker muscular dystrophy by assessing the integrity and function of the muscles. During an EMG, small electrodes are inserted into the muscles, and the electrical signals produced by the muscles are recorded and analyzed.
In individuals with BMD, the EMG may show abnormal electrical activity, indicating muscle fiber damage and weakness. However, it is important to note that EMG findings alone are not sufficient for a definitive diagnosis of BMD, as they can also be seen in other neuromuscular conditions.
Muscle biopsy involves the removal of a small sample of muscle tissue for microscopic examination. It can provide valuable information about the structure and composition of the muscle fibers. In Becker muscular dystrophy, the muscle biopsy may reveal characteristic changes, such as muscle fiber degeneration, regeneration, and fibrosis.
However, muscle biopsy is not always necessary for the diagnosis of BMD, especially when genetic testing and clinical evaluation are conclusive. It is usually reserved for cases where the diagnosis is uncertain or when additional information is needed.
In addition to the aforementioned methods, other diagnostic tests may be performed to support the diagnosis of Becker muscular dystrophy:
Diagnosing Becker muscular dystrophy involves a combination of medical history, physical examination, genetic testing, electromyography, and sometimes muscle biopsy. Genetic testing is the most definitive method, as it can identify specific mutations in the dystrophin gene associated with BMD. Other diagnostic tests, such as blood tests, cardiac evaluation, and imaging studies, may also be performed to support the diagnosis and assess the extent of muscle and organ involvement.